Cure Leukaemia partner with
Straight & Narrow Drinks
Straight & Narrow will be partnering on a number of Cure Leukaemia’s major events going forward with the major collaboration due to be announced in the next few weeks. Straight & Narrow will also be donating a percentage of the company’s annual profits to Cure Leukaemia.
All funds raised by Straight & Narrow will be invested in the national Trials Acceleration Programme (TAP) which Cure Leukaemia began funding in January 2020.
Consisting of specialist research nurses in 12 of the UK’s biggest cities and a facilitatory Hub at the Queen Elizabeth Hospital in Birmingham, TAP enables blood cancer clinical trials to run at an accelerated rate. These trials benefit blood cancer patients from a catchment area of over 20 million people giving the 38,000 people diagnosed with a form of blood cancer in the UK each year the chance to access potentially lifesaving treatments not currently available through standard care.
CEO and founder of the company, Jason Stoneham from Shropshire, heard about the work of national blood cancer charity Cure Leukaemia in 2019 when he took part in their London 2 Paris closed-road cycling event. Inspired by meeting patients and other members of the charity during the 4-day event, Jason believes that it is the perfect cause to align his new company with.